On 20 December 2017, the French Competition Authority (the FCA) imposed a EUR 25 million fine on a pharmaceutical laboratory, for delaying entry onto the market of the generic version of Durogesic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback